Atrys Health, S.A. (BME:ATRY)
2.370
-0.045 (-1.86%)
Jul 17, 2026, 5:35 PM CET
Atrys Health Revenue
In the year 2025, Atrys Health had annual revenue of 146.37M EUR with 3.35% growth. Atrys Health had revenue of 73.24M in the half year ending December 31, 2025, a decrease of -15.17%.
Revenue
146.37M
Revenue Growth
+3.35%
P/S Ratio
1.25
Revenue / Employee
219.99K
Employees
758
Market Cap
179.90M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 146.37M | 4.74M | 3.35% |
| Dec 31, 2024 | 141.63M | -65.37M | -31.58% |
| Dec 31, 2023 | 207.00M | 42.86M | 26.11% |
| Dec 31, 2022 | 164.14M | 36.30M | 28.39% |
| Dec 31, 2021 | 127.84M | 93.12M | 268.23% |
| Dec 31, 2020 | 34.72M | 17.74M | 104.45% |
| Dec 31, 2019 | 16.98M | 7.36M | 76.57% |
| Dec 31, 2018 | 9.62M | 1.29M | 15.44% |
| Dec 31, 2017 | 8.33M | 2.00M | 31.54% |
| Dec 31, 2016 | 6.33M | 1.72M | 37.35% |
| Dec 31, 2015 | 4.61M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.44B |
| Almirall | 1.12B |
| Laboratorios Farmaceuticos Rovi | 741.09M |
| Faes Farma | 674.06M |
| Laboratorio Reig Jofre | 335.01M |
| Clínica Baviera | 304.91M |
| Prim, S.A. | 251.89M |
| Labiana Health | 76.44M |
Atrys Health News
- 2 months ago - Atrys Health Slides: Q1 2026 - Filings
- 2 months ago - Atrys Health Earnings release: Q1 2026 - Filings
- 3 months ago - Atrys Health Earnings release: Q4 2025 - Filings
- 3 months ago - Atrys Health Slides: Q4 2025 - Filings
- 8 months ago - Atrys Health Earnings release: Q3 2025 - Filings
- 8 months ago - Atrys Health Slides: Q3 2025 - Filings
- 10 months ago - Atrys Health Quarterly report: Q2 2025 - Filings
- 10 months ago - Atrys Health Slides: Q2 2025 - Filings